Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 31;37(4):310-312.
doi: 10.4285/kjt.23.0050. Epub 2023 Nov 23.

Sirolimus-induced leukocytoclastic vasculitis

Vishal Ramteke  1 , Sainath Pattewar  2 , Nitin Barde  3 , Nishant Deshpande  1
Affiliations

Sirolimus-induced leukocytoclastic vasculitis

Vishal Ramteke et al. Korean J Transplant. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1
(A, B) Image showing non-pruritic ulcerative lesions with scales over the great and little toes.
Fig. 2
Fig. 2
(A, B) Image showing resolution of the skin lesions with residual hyperpigmentation on the great and little toes after discontinuing sirolimus.
See this image and copyright information in PMC

References

    1. Fiorentino DF. Cutaneous vasculitis. J Am Acad Dermatol. 2003;48:311–40. doi: 10.1067/mjd.2003.212. - DOI - PubMed
    1. Hardinger KL, Cornelius LA, Trulock EP, 3rd, Brennan DC. Sirolimus-induced leukocytoclastic vasculitis. Transplantation. 2002;74:739–43. doi: 10.1097/00007890-200209150-00025. - DOI - PubMed
    1. Pasqualotto AC, Bianco PD, Sukiennik TC, Furian R, Garcia VD. Sirolimus-induced leukocytoclastic vasculitis: the second case reported. Am J Transplant. 2004;4:1549–51. doi: 10.1111/j.1600-6143.2004.00513.x. - DOI - PubMed

LinkOut - more resources